Sanofi and Regeneron’s Dupixent shows positive results in phase 3 trial
Trial focusing on children with eosinophilic oesophagitis has met its primary endpoint
Read More
Tag: eosinophilic oesophagitis
FDA green light for Fasenra
Currently there are no FDA-approved treatments for eosinophilic oesophagitis.
Read More
UK launch for first eosinophilic oesophagitis drug
Dr Falk Pharma has launched Jorveza – the first globally licensed drug approved for eosinophilic oesophagitis – across the UK.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
